FOYA Program

Media & Press Releases
02 February 2024
ISPE President and CEO Thomas Hartman provides insights on how AI may impact the biotech industry in 2024. Thomas observes that the meteoric rise of AI took every industry by surprise in 2023. In 2024, he notes, “companies will have more time to take...
Media & Press Releases
01 February 2024
ISPE President and CEO Thomas Hartman calls attention to the importance of addressing drug shortages in 2024 in part three of an article, “Scrip Asks…What Does 2024 Hold for Biopharma?” The article features expert insights on manufacturing and supply...
Media & Press Releases
12 January 2024
Thomas Hartman, President and CEO of ISPE, has been featured in a recent podcast episode with Life Science Success. He and the host, Don Davis, discuss Hartman’s career journey and the impact ISPE is having on the industry. Hartman touches on...
Media & Press Releases
04 January 2024
Thomas Hartman, President and CEO of the International Society for Pharmaceutical Engineering, is among several key industry leaders featured in this article, discussing the advantages and challenges associated with integrating AI into drug...
Media & Press Releases
18 December 2023
The COVID-19 pandemic has prompted regulators and the industry to consider how best to prepare for future emergencies. In June 2023, the European Commission finalized deals with various European pharmaceutical companies to reserve manufacturing...
Media & Press Releases
05 December 2023
Leaders from the pharmaceutical industry are providing suggestions to their peers and colleagues, in anticipation of continued supply chain shortages next year. Among them, Omair Ahmed, COO, Nexus Pharmaceuticals, and member of ISPE, recommends...
Media & Press Releases
12 October 2023
The pharmaceutical industry’s best and brightest recognized on October 15 at ISPE Annual Meeting & Expo in Las Vegas Las Vegas, Nevada, USA, October 12, 2023 – ISPE is set to unveil the recipient of the prestigious 2023 Facility of the Year Award...